It has been demonstrated that Rac1 is a key molecule in regulating the invasiveness of PTC, and our previous research found that TIPE2 functions through inhibiting Rac1 in hepatocellular carcinoma (HCC) and non-small cell lung cancer (NSCLC) [14, 16]. The gene discussed is RAC1; the disease is non-small cell lung carcinoma.